Patent Assignment
Reel/Frame 012280/0901
Assignment of Assignor's Interest
Recorded: 2002-01-08
Pages: 15
Assignor
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Executed: 2001-11-30
Assignee
GENCELL, INC.
300 SOMERSET CORPORATE BLVD., BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(24)
Recombinant Dna Vector Encoding Human Endothelial Cell Growth Factor
Patent:
4,868,113 →
Application:
06/835,594 →
Production of Recombinant Adeno-Associated Virus Vectors
Patent:
5,173,414 →
Application:
07/605,775 →
Production of Recombinant Adeno-Associated Virus Vectors
Patent:
5,354,678 →
Application:
07/993,776 →
Adeno-Associated Viral (Aav) Liposomes and Methods Related Thereto
Patent:
5,834,441 →
Application:
08/305,221 →
Fibroblast Growth Factor Receptors
Patent:
6,344,546 →
Application:
08/323,430 →
Bovine B-Endothelial Cell Growth Factor
Patent:
5,552,528 →
Application:
08/334,884 →
Human Bek Fibroblast Growth Factor Receptor
Patent:
5,863,888 →
Application:
08/451,822 →
Use of Fibroblast Growth Factors to Stimulate Bone Growth
Patent:
5,656,598 →
Application:
08/454,964 →
Adeno-Associated Viral (Aav) Liposomes and Methods Related Thereto
Patent:
5,861,171 →
Application:
08/458,342 →
Use of Fibroblast Growth Factors to Stimulate Bone Growth
Patent:
5,614,496 →
Application:
08/458,634 →
Method for Producing Recombinant Adeno-Associated Virus Vectors
Patent:
5,681,731 →
Application:
08/459,049 →
Recombinant Adeno-Associated Virus Vector Packaging Cells and Methods for Use
Patent:
5,691,176 →
Application:
08/459,091 →
Recombinant Adeno-Associated Virus Vectors
Patent:
5,780,280 →
Application:
08/459,352 →
Adeno-Associated Viral (Aav) Liposomes and Methods Related Thereto
Patent:
5,861,314 →
Application:
08/471,603 →
Recombinant Human Endothelial Cell Growth Factor
Patent:
5,571,790 →
Application:
08/472,964 →
Recombinant Adeno-Associated Virus Vectors
Patent:
5,589,377 →
Application:
08/490,095 →
Compositions of Human Endothelial Cell Growth Factor
Patent:
5,827,826 →
Application:
08/743,261 →
Dna Encoding Human Endothelial Cell Growth Factors and Plasmids Comprising Said Dna
Patent:
5,849,538 →
Application:
08/840,088 →
Adeno-Associated Viral Liposomes and Their Use in Transfecting Dendritic Cells to Stimulate Specific Immunity
Patent:
6,652,850 →
Application:
09/000,003 →
Akt Nucleic Acids, Polypeptides, and Uses Thereof
Dna Encoding Human Endothelial Cell Growth Factes and Plasmids Comprising Said Dna
Patent:
38,240 →
Application:
09/538,305 →
Recombinant Human Endothelial Cell Growth Factor
Patent:
37,850 →
Application:
09/538,857 →
Adenovirus formulations for gene therapy
Application:
09/763,210 →
Neutral and anionic colloidal particles for gene delivery
Application:
60/253,827 →
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 6, 1996
From: JAYE, MICHAEL C.; DUNSTAN, COLIN R.; IZBICKA, ELZBIETA; MUNDY, GREGORY R.
To: RHONE-POULENC RORER PHARMACEUTICALS INC.; OSTEOSA INC.
Reel/Frame 008120/0495 →
Change of Name
Oct 4, 2001
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 012037/0601 →
Change of Name
Oct 4, 2001
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 012036/0167 →
Assignment of Assignor's Interest
Dec 18, 2003
From: GENCELL, INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 014207/0691 →
Assignment of Assignor's Interest
May 17, 2004
From: GENCELL, INC.
To: GENCELL, S.A.
Reel/Frame 015341/0787 →
Assignment of Assignor's Interest
Oct 1, 2004
From: GUO, KUN; PAGNONI, MARCO F.; CLARK, KENNETH L.; IVASHCHENKO, YURI D.
To: RHONE-POULENC RORER PHARMACEUTICALS, INC.
Reel/Frame 015208/0197 →
Corrective Assignment to Correct the Corrective Assignment to Re-Record Assignment to Correct the Serial Number from 09/526343 to 09/526043 Previously Recorded on Reel 015208 Frame 0223. Assignor(S) Hereby Confirms the Change of Name.
Oct 14, 2004
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 015250/0288 →
Corrective Assignment to Correct the Corrective Assignment to Re-Record Assignment to Correct the Serial Number from 09/526343 to 09/526043 Previously Recorded on Reel 015208 Frame 0226. Assignor(S) Hereby Confirms the Change of Name.
Oct 14, 2004
From: AVENTIS PHARMACEUTICALS PRODUCTS INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 015250/0307 →
Assignment of Assignor's Interest
Nov 28, 2005
From: GENCELL S.A.S.
To: CENTELION
Reel/Frame 017268/0028 →
Certificate of Conversion
Dec 9, 2014
From: AVENTISUB INC.
To: AVENTISUB LLC
Reel/Frame 034566/0976 →
Merger
Jan 19, 2015
From: AVENTIS PHARMACEUTICALS INC.
To: AVENTISUB LLC
Reel/Frame 034781/0334 →